Two recent reports showed that administration of DEX decreased human lung fibroblast levels of TGF-β1 and TGF-β2 mRNA47 and inhibited TGF-β mediated promoter in mouse fibrosarcoma L929 cells48. Here, TGFB2 is linked to fibrosarcoma.